Rothschild & Co Asset Management US’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-38,493
| Closed | -$3.45M | – | 375 |
|
|
2018
Q2 | $3.45M | Sell |
38,493
-37,112
| -49% | -$3.33M | 0.04% | 314 |
|
|
2018
Q1 | $5.53M | Sell |
75,605
-8,129
| -10% | -$595K | 0.06% | 285 |
|
|
2017
Q4 | $4.86M | Sell |
83,734
-5,444
| -6% | -$316K | 0.05% | 284 |
|
|
2017
Q3 | $4M | Buy |
89,178
+1,320
| +2% | +$59.2K | 0.04% | 283 |
|
|
2017
Q2 | $3.47M | Buy |
87,858
+269
| +0.3% | +$10.6K | 0.04% | 295 |
|
|
2017
Q1 | $3.55M | Sell |
87,589
-3,656
| -4% | -$148K | 0.04% | 292 |
|
|
2016
Q4 | $3.67M | Buy |
91,245
+5,066
| +6% | +$204K | 0.05% | 304 |
|
|
2016
Q3 | $3.12M | Buy |
86,179
+73
| +0.1% | +$2.64K | 0.05% | 291 |
|
|
2016
Q2 | $2.5M | Sell |
86,106
-5,493
| -6% | -$159K | 0.05% | 308 |
|
|
2016
Q1 | $3.2M | Sell |
91,599
-2,716
| -3% | -$95K | 0.06% | 286 |
|
|
2015
Q4 | $3.04M | Sell |
94,315
-341,399
| -78% | -$11M | 0.06% | 298 |
|
|
2015
Q3 | $14.1M | Buy |
435,714
+11,665
| +3% | +$377K | 0.28% | 128 |
|
|
2015
Q2 | $17.5M | Buy |
424,049
+17,183
| +4% | +$711K | 0.32% | 101 |
|
|
2015
Q1 | $18.3M | Sell |
406,866
-14,705
| -3% | -$661K | 0.35% | 97 |
|
|
2014
Q4 | $15.8M | Buy |
+421,571
| New | +$15.8M | 0.31% | 102 |
|